Evan M Hersh

  • 19105 Citations
  • 67 h-Index
1965 …2021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1965 2017

  • 19105 Citations
  • 67 h-Index
  • 490 Article
  • 48 Chapter
  • 3 Letter
  • 1 Conference contribution
Filter
Article
2017
19 Citations (Scopus)

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

MMAIT-IV Clinical Trial Group, Dec 1 2017, In : Annals of Surgical Oncology. 24, 13, p. 3991-4000 10 p.

Research output: Contribution to journalArticle

Mycobacterium bovis
Immunotherapy
Melanoma
Neoplasm Metastasis
Survival
2015
2 Citations (Scopus)

A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma

Cohen, S. J., Zalupski, M. M., Conkling, P., Nugent, F., Ma, W. W., Modiano, M., Pascual, R., Lee, F. C., Wong, L. & Hersh, E. M., Dec 24 2015, (Accepted/In press) In : American Journal of Clinical Oncology: Cancer Clinical Trials.

Research output: Contribution to journalArticle

gemcitabine
Multicenter Studies
Adenocarcinoma
Placebos
Drug Therapy
22 Citations (Scopus)

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Hersh, E. M., Del Vecchio, M., Brown, M. P., Kefford, R., Loquai, C., Testori, A., Bhatia, S., Gutzmer, R., Conry, R., Haydon, A., Robert, C., Ernst, S., Homsi, J., Grob, J. J., Kendra, K., Agarwala, S. S., Li, M., Clawson, A., Brachmann, C., Karnoub, M. & 3 others, Elias, I., Renschler, M. F. & Hauschild, A., Nov 1 2015, In : Annals of Oncology. 26, 11, p. 2267-2274 8 p., mdv324.

Research output: Contribution to journalArticle

Dacarbazine
Melanoma
Drug Therapy
Disease-Free Survival
Confidence Intervals
2012
8 Citations (Scopus)
Melanoma
Drug Therapy
Investigational Therapies
Immunosuppressive Agents
Therapeutics
2011
208 Citations (Scopus)

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

Hersh, E. M., O'Day, S. J., Powderly, J., Khan, K. D., Pavlick, A. C., Cranmer, L. D., Samlowski, W. E., Nichol, G. M., Yellin, M. J. & Weber, J. S., Jun 2011, In : Investigational New Drugs. 29, 3, p. 489-498 10 p.

Research output: Contribution to journalArticle

Dacarbazine
Multicenter Studies
Melanoma
Drug Therapy
ipilimumab
2010
16 Citations (Scopus)

A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma

Weber, J. S., Samlowski, W. E., Gonzalez, R., Ribas, A., Stephenson, J., O'Day, S., Sato, T., Dorr, R. T., Grenier, K. & Hersh, E. M., Aug 1 2010, In : Cancer. 116, 15, p. 3683-3691 9 p.

Research output: Contribution to journalArticle

Dacarbazine
Melanoma
Maximum Tolerated Dose
Pharmacokinetics
Survival
85 Citations (Scopus)

A phase 2 clinical trial of nab-Paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma

Hersh, E. M., O'Day, S. J., Ribas, A., Samlowski, W. E., Gordon, M. S., Shechter, D. E., Clawson, A. A. & Gonzalez, R., Jan 1 2010, In : Cancer. 116, 1, p. 155-163 9 p.

Research output: Contribution to journalArticle

Melanoma
Clinical Trials
Drug Therapy
Survival
Albumin-Bound Paclitaxel
18 Citations (Scopus)

A phase i study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

Cohen, S. J., Zalupski, M. M., Modiano, M. R., Conkling, P., Patt, Y. Z., Davis, P., Dorr, R. T., Boytim, M. L. & Hersh, E. M., Jul 2010, In : Cancer Chemotherapy and Pharmacology. 66, 2, p. 287-294 8 p.

Research output: Contribution to journalArticle

gemcitabine
Pancreatic Neoplasms
Toxicity
Maximum Tolerated Dose
Abdominal Pain
20 Citations (Scopus)

A phase i trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer

Moulder, S., Dhillon, N., Ng, C., Hong, D., Wheler, J., Naing, A., Tse, S., La Paglia, A., Dorr, R. T., Hersh, E. M., Boytim, M. & Kurzrock, R., Oct 2010, In : Investigational New Drugs. 28, 5, p. 634-640 7 p.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Reactive Oxygen Species
Prostatic Neoplasms
Breast
31 Citations (Scopus)

Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma

Ribas, A., Camacho, L. H., Lee, S. M., Hersh, E. M., Brown, C. K., Richards, J. M., Rodriguez, M. J., Prieto, V. G., Glaspy, J. A., Oseguera, D. K., Hernandez, J., Villanueva, A., Chmielowski, B., Mitsky, P., Bercovici, N., Wasserman, E., Landais, D. & Ross, M. I., Sep 27 2010, In : Journal of Translational Medicine. 8, 89.

Research output: Contribution to journalArticle

Dendritic Cells
Melanoma
Cells
Cell Line
Tumors
46 Citations (Scopus)

Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma

Koyanagi, K., O'Day, S. J., Boasberg, P., Atkins, M. B., Wang, H. J., Gonzalez, R., Lewis, K., Thompson, J. A., Anderson, C. M., Lutzky, J., Amatruda, T. T., Hersh, E. M., Richards, J., Weber, J. S. & Hoon, D. S. B., Apr 15 2010, In : Clinical Cancer Research. 16, 8, p. 2402-2408 7 p.

Research output: Contribution to journalArticle

Circulating Neoplastic Cells
Biological Therapy
Melanoma
Tumor Biomarkers
Maintenance
4 Citations (Scopus)

Whole-brain radiation therapy in melanoma: an open question

Cranmer, L. D., Jeter, J. M., Morgan, S. S., Hersh, E. M. & Stea, B., Jan 2010, In : The Lancet Oncology. 11, 1, p. 13 1 p.

Research output: Contribution to journalArticle

Cranial Irradiation
Brain Neoplasms
Patient Selection
Melanoma
Radiotherapy
2009
30 Citations (Scopus)

Phase II multicenter trial of maintenance biotherapy after induction concurrent biochemotherapy for patients with metastatic melanoma

O'Day, S. J., Atkins, M. B., Boasberg, P., Wang, H. J., Thompson, J. A., Anderson, C. M., Gonzalez, R., Lutzky, J., Amatruda, T., Hersh, E. M. & Weber, J. S., Dec 20 2009, In : Journal of Clinical Oncology. 27, 36, p. 6207-6212 6 p.

Research output: Contribution to journalArticle

Biological Therapy
Multicenter Studies
Melanoma
Maintenance
Survival
2008
215 Citations (Scopus)

Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: A report from the 11715 study group

McDermott, D. F., Sosman, J. A., Gonzalez, R., Hodi, F. S., Linette, G. P., Richards, J., Jakub, J. W., Beeram, M., Tarantolo, S., Agarwala, S., Frenette, G., Puzanov, I., Cranmer, L. D., Lewis, K., Kirkwood, J., White, J. M., Xia, C., Patel, K. & Hersh, E. M., 2008, In : Journal of Clinical Oncology. 26, 13, p. 2178-2185 8 p.

Research output: Contribution to journalArticle

Dacarbazine
Melanoma
Placebos
Survival
Survival Rate
57 Citations (Scopus)

Phase 1 trial of intranodal injection of a melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma

Weber, J., Boswell, W., Smith, J., Hersh, E. M., Snively, J., Diaz, M., Miles, S., Liu, X., Obrocea, M., Qiu, Z. & Bot, A., Feb 2008, In : Journal of Immunotherapy. 31, 2, p. 215-223 9 p.

Research output: Contribution to journalArticle

MART-1 Antigen
DNA Vaccines
Melanoma
Plasmids
Injections
300 Citations (Scopus)

Phase I/II study of ipilimumab for patients with metastatic melanoma

Weber, J. S., O'Day, S., Urba, W., Powderly, J., Nichol, G., Yellin, M., Snively, J. & Hersh, E. M., Dec 20 2008, In : Journal of Clinical Oncology. 26, 36, p. 5950-5956 7 p.

Research output: Contribution to journalArticle

Melanoma
Maximum Tolerated Dose
ipilimumab
Hybridomas
Tumor Burden
2007
40 Citations (Scopus)

Phase I trial of imexon in patients with advanced malignancy

Dragovich, T., Gordon, M., Mendelson, D., Wong, L., Modiano, M., Chow, H-H., Samulitis, B., O'Day, S., Grenier, K., Hersh, E. M. & Dorr, R. T., May 1 2007, In : Journal of Clinical Oncology. 25, 13, p. 1779-1784 6 p.

Research output: Contribution to journalArticle

Sulfhydryl Compounds
Neoplasms
Maximum Tolerated Dose
Reactive Oxygen Species
Pharmacokinetics
46 Citations (Scopus)

The role of the CTLA4 blockade in the treatment of malignant melanoma

Cranmer, L. D. & Hersh, E. M., Oct 2007, In : Cancer Investigation. 25, 7, p. 613-631 19 p.

Research output: Contribution to journalArticle

CTLA-4 Antigen
Melanoma
Immunologic Adjuvants
Cancer Vaccines
Colectomy
2006
496 Citations (Scopus)

Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: The oblimersen melanoma study group

Bedikian, A. Y., Millward, M., Pehamberger, H., Conry, R., Gore, M., Trefzer, U., Pavlick, A. C., DeConti, R., Hersh, E. M., Hersey, P., Kirkwood, J. M. & Haluska, F. G., Oct 10 2006, In : Journal of Clinical Oncology. 24, 29, p. 4738-4745 8 p.

Research output: Contribution to journalArticle

Dacarbazine
Melanoma
L-Lactate Dehydrogenase
Survival
Serum
12 Citations (Scopus)

Preclinical antitumor activity, pharmacokinetics and pharmacodynamics of imexon in mice

Pourpak, A., Meyers, R. O., Samulitis, B. K., Chow, H-H., Kepler, C. Y., Raymond, M. A., Hersh, E. M. & Dorr, R. T., Nov 2006, In : Anti-Cancer Drugs. 17, 10, p. 1179-1184 6 p.

Research output: Contribution to journalArticle

Pharmacokinetics
Sulfhydryl Compounds
Cystine
Maximum Tolerated Dose
Biomarkers
2005
38 Citations (Scopus)

A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors

Ebbinghaus, S., Rubin, E., Hersh, E. M., Cranmer, L. D., Bonate, P. L., Fram, R. J., Jekunen, A., Weitman, S. & Hammond, L. A., Nov 1 2005, In : Clinical Cancer Research. 11, 21, p. 7807-7816 10 p.

Research output: Contribution to journalArticle

Maximum Tolerated Dose
Neoplasms
Neutropenia
Fatigue
Melanoma
214 Citations (Scopus)

Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies

Nyman, D. W., Campbell, K. J., Hersh, E. M., Long, K., Richardson, K., Trieu, V., Desai, N., Hawkins, M. J. & Von Hoff, D. D., 2005, In : Journal of Clinical Oncology. 23, 31, p. 7785-7793 9 p.

Research output: Contribution to journalArticle

Paclitaxel
Nanoparticles
Pharmacokinetics
Castor Oil
Neoplasms
27 Citations (Scopus)

Rodent models of brain metastasis in melanoma

Cranmer, L. D., Trevor, K. T., Bandlamuri, S. & Hersh, E. M., 2005, In : Melanoma Research. 15, 5, p. 325-356 32 p.

Research output: Contribution to journalArticle

Rodentia
Melanoma
Neoplasm Metastasis
Brain
Blood-Brain Barrier
2004
18 Citations (Scopus)

A Phase II Trial of Vinorelbine Tartrate in Patients with Disseminated Malignant Melanoma and One Prior Systemic Therapy: A Southwest Oncology Group Study

Whitehead, R. P., Moon, J., McCachren, S. S., Hersh, E. M., Samlowski, W. E., Beck, J. T., Tchekmedyian, N. S. & Sondak, V. K., Apr 15 2004, In : Cancer. 100, 8, p. 1699-1704 6 p.

Research output: Contribution to journalArticle

Melanoma
Therapeutics
Confidence Intervals
vinorelbine
Disease-Free Survival
128 Citations (Scopus)

Clinical applications of dendritic cell vaccination in the treatment of cancer

Cranmer, L. D., Trevor, K. T. & Hersh, E. M., Apr 2004, In : Cancer Immunology, Immunotherapy. 53, 4, p. 275-306 32 p.

Research output: Contribution to journalArticle

Dendritic Cells
Vaccination
Cell- and Tissue-Based Therapy
Neoplasms
Antigens
49 Citations (Scopus)

Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application

Trevor, K. T., Cover, C., Ruiz, Y. W., Akporiaye, E. T., Hersh, E. M., Landais, D., Taylor, R. R., King, A. D. & Walters, R. E., Aug 2004, In : Cancer Immunology, Immunotherapy. 53, 8, p. 705-714 10 p.

Research output: Contribution to journalArticle

Hybrid Cells
Dendritic Cells
Vaccines
Neoplasms
T-Lymphocytes
2003
3 Citations (Scopus)
Granulocyte-Macrophage Colony-Stimulating Factor
Coculture Techniques
Interleukin-4
Dendritic Cells
Monocytes
104 Citations (Scopus)

Naturally occurring B-cell responses to breast cancer

Coronella-Wood, J. A. & Hersh, E. M., Dec 2003, In : Cancer Immunology, Immunotherapy. 52, 12, p. 715-738 24 p.

Research output: Contribution to journalArticle

B-Lymphocytes
Breast Neoplasms
Antibody Formation
Neoplasms
Neoplasm Antigens
2002
103 Citations (Scopus)

Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast

Coronella, J. A., Perry, C. S., Welch, M., Trevor, K. T., Stopeck, A. T., Villar, H. & Hersh, E. M., Aug 15 2002, In : Journal of Immunology. 169, 4, p. 1829-1836 8 p.

Research output: Contribution to journalArticle

Carcinoma, Ductal, Breast
B-Lymphocytes
Antigens
Neoplasms
Ductal Carcinoma
142 Citations (Scopus)

Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma

Agarwala, S. S., Glaspy, J., O'Day, S. J., Mitchell, M., Gutheil, J., Whitman, E., Gonzalez, R., Hersh, E. M., Feun, L., Belt, R., Meyskens, F., Hellstrand, K., Wood, D., Kirkwood, J. M., Gehlsen, K. R. & Naredi, P., Jan 1 2002, In : Journal of Clinical Oncology. 20, 1, p. 125-133 9 p.

Research output: Contribution to journalArticle

Histamine
Interleukin-2
Melanoma
Survival
Therapeutics
2001
37 Citations (Scopus)

A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors

Taylor, C. W., Dorr, R. T., Fanta, P., Hersh, E. M. & Salmon, S. E., 2001, In : Cancer Chemotherapy and Pharmacology. 47, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

Pharmacodynamics
Asparaginase
Tumors
Asparagine
Neoplasms
139 Citations (Scopus)

Gene delivery using ultrasound contrast agents

Unger, E. C., Hersh, E. M., Vannan, M. & McCreery, T., 2001, In : Echocardiography. 18, 4, p. 355-361 7 p.

Research output: Contribution to journalArticle

Microbubbles
Contrast Media
Genes
Genetic Therapy
DNA
237 Citations (Scopus)

Local drug and gene delivery through microbubbles

Unger, E. C., Hersh, E. M., Vannan, M., Matsunaga, T. O. & McCreery, T., 2001, In : Progress in Cardiovascular Diseases. 44, 1, p. 45-54 10 p.

Research output: Contribution to journalArticle

Microbubbles
Pharmaceutical Preparations
Genes
Contrast Media
Genetic Therapy
108 Citations (Scopus)

Phase II study of direct intralesional gene transfer of Allovectin-7, an HLA-B7/β2-microglobulin DNA-liposome complex, in patients with metastatic melanoma

Stopeck, A. T., Jones, A., Hersh, E. M., Thompson, J. A., Finucane, D. M., Gutheil, J. C. & Gonzalez, R., 2001, In : Clinical Cancer Research. 7, 8, p. 2285-2291 7 p.

Research output: Contribution to journalArticle

HLA-B7 Antigen
Liposomes
Melanoma
DNA
Genes
15 Citations (Scopus)

Preclinical antitumor activity of the azonafide series of anthracene-based DNA intercalators

Dorr, R. T., Liddil, J. D., Sami, S. M., Remers, W., Hersh, E. M. & Alberts, D. S., 2001, In : Anti-Cancer Drugs. 12, 3, p. 213-220 8 p.

Research output: Contribution to journalArticle

Intercalating Agents
Adenosine Monophosphate
DNA
Lung Neoplasms
Neoplasms
40 Citations (Scopus)

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2

Trevor, K. T., Hersh, E. M., Brailey, J., Balloul, J. M. & Acres, B., 2001, In : Cancer Immunology, Immunotherapy. 50, 8, p. 397-407 11 p.

Research output: Contribution to journalArticle

Vaccinia virus
Dendritic Cells
Interleukin-2
Vaccinia
Transgenes
2000
5 Citations (Scopus)

Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft

Clark, P. R., Stopeck, A. T., Parker, S. E. & Hersh, E. M., Sep 15 2000, In : Cellular Immunology. 204, 2, p. 96-104 9 p.

Research output: Contribution to journalArticle

SCID Mice
Transgenes
Heterografts
Natural Killer Cells
Interleukin-2
39 Citations (Scopus)

Heat-inducible vectors for use in gene therapy

Gerner, E. W., Hersh, E. M., Pennington, M., Tsang, T. C., Harris, D. T., Vasanwala, F. & Brailey, J., Mar 2000, In : International Journal of Hyperthermia. 16, 2, p. 171-181 11 p.

Research output: Contribution to journalArticle

Genetic Therapy
Shock
Hot Temperature
Interleukin-2
Temperature
55 Citations (Scopus)

Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma

Stopeck, A. T., Gessner, A., Miller, T. P., Hersh, E. M., Johnson, C. S., Cui, H., Frutiger, Y. & Grogan, T. M., 2000, In : Clinical Cancer Research. 6, 10, p. 3904-3909 6 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Lymphoma, Large B-Cell, Diffuse
T-Lymphocytes
Neoplasms
HLA-DR Antigens
9 Citations (Scopus)

Natural and induced human antibody response to cancer

Lake, D. F., Huynh, W. C. & Hersh, E. M., 2000, In : Cancer Investigation. 18, 5, p. 480-489 10 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Cancer Vaccines
Skin Neoplasms
Neoplasm Antigens
Antibody Formation
29 Citations (Scopus)

Studies of direct intratumoral gene transfer using cationic lipid- complexed plasmid DNA

Clark, P. R., Stopeck, A. T., Ferrari, M., Parker, S. E. & Hersh, E. M., 2000, In : Cancer Gene Therapy. 7, 6, p. 853-860 8 p.

Research output: Contribution to journalArticle

Plasmids
Lipids
DNA
Genes
Interleukin-2
1999
76 Citations (Scopus)

Cationic lipid-mediated gene transfer: Current concepts

Clark, P. R. & Hersh, E. M., Apr 1999, In : Current Opinion in Molecular Therapeutics. 1, 2, p. 158-176 19 p.

Research output: Contribution to journalArticle

Lipids
Genes
Genetic Therapy
Clinical Trials
Technology
14 Citations (Scopus)

Clinical aspects of intratumoral gene therapy

Akporiaye, E. T. & Hersh, E. M., 1999, In : Current Opinion in Molecular Therapeutics. 1, 4, p. 443-453 11 p.

Research output: Contribution to journalArticle

Genetic Therapy
Genes
Neoplasms
Clinical Trials
91 Citations (Scopus)

Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: Phase I/II experience

Galanis, E., Hersh, E. M., Stopeck, A. T., Gonzalez, R., Burch, P., Perry, C. S., Akporiaye, E. T., Rinehart, J. J., Edmonson, J., Sobol, R. E., Forscher, C., Sondak, V. K., Lewis, B. D., Unger, E. C., O'Driscoll, M., Selk, L. & Rubin, J., Oct 1999, In : Journal of Clinical Oncology. 17, 10, p. 3313-3323 11 p.

Research output: Contribution to journalArticle

Ethanolamine
Immunotherapy
Interleukin-2
Lipids
DNA
17 Citations (Scopus)

Novel antitumor 2-cyanoaziridine-1-carboxamides

Iyengar, B. S., Dorr, R. T., Alberts, D. S., Hersh, E. M., Salmon, S. E. & Remers, W. A., 1999, In : Journal of Medicinal Chemistry. 42, 3, p. 510-514 5 p.

Research output: Contribution to journalArticle

Tumors
Isocyanates
Mitoxantrone
Cell culture
Doxorubicin
11 Citations (Scopus)

Phase II trial of biochemotherapy with interferon α, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: A Southwest Oncology Group trial

Margolin, K. A., Liu, P. Y., Unger, J. M., Fletcher, W. S., Flaherty, L. E., Urba, W. J., Hersh, E. M., Hutchins, L. E., Sosman, J. A., Smith, J. W., Weiss, G. R. & Sondak, V. K., 1999, In : Journal of Cancer Research and Clinical Oncology. 125, 5, p. 292-296 5 p.

Research output: Contribution to journalArticle

Dacarbazine
Tamoxifen
Interferons
Cisplatin
Melanoma
32 Citations (Scopus)

Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells

Clark, P. R., Stopeck, A. T., Brailey, J. L., Wang, Q., McArthur, J., Finer, M. H. & Hersh, E. M., 1999, In : Cancer Gene Therapy. 6, 5, p. 437-446 10 p.

Research output: Contribution to journalArticle

Transgenes
Adenoviridae
Lipids
Protamines
Neoplasms
96 Citations (Scopus)
Dimethyl Sulfoxide
Doxorubicin
Refractory materials
Chemotherapy
Cytarabine
1998
22 Citations (Scopus)

Transfection of primary tumor cells and tumor cell lines with plasmid DNA/lipid complexes

Stopeck, A. T., Hersh, E. M., Brailey, J. L., Clark, P. R., Norman, J. & Parker, S. E., 1998, In : Cancer Gene Therapy. 5, 2, p. 119-126 8 p.

Research output: Contribution to journalArticle

Tumor Cell Line
Transfection
Plasmids
Lipids
Interleukin-2
1997
30 Citations (Scopus)

Advances in the biological therapy and gene therapy of malignant disease

Hersh, E. M. & Stopeck, A. T., Dec 1997, In : Clinical Cancer Research. 3, 12 II, p. 2623-2629 7 p.

Research output: Contribution to journalArticle

Biological Therapy
Genetic Therapy
Neoplasms
HLA-B7 Antigen
Immune Evasion